The Conquest of Infectious Diseases: Who Are We Kidding?
Authors: Ruth L. Berkelman
Journal: Annals of Internal Medicine (1993)

Editorials1 September 1993The Conquest of Infectious Diseases: Who Are We Kidding?Ruth L. Berkelman, MD and James M. Hughes, MDRuth L. Berkelman, MDNational Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333. and James M. Hughes, MDNational Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-119-5-199309010-00014 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail The 20th century has seen unprecedented scientific progress and so it is ironic that as the century draws to a close, scientists and clinicians must learn to deal with emerging new infectious agents whose existence in human beings was proved only in the past few years [1].Almost a quarter century ago, the Surgeon General of the United States testified to Congress that it was time to close the book on infectious diseases [2]. The wide use of effective antibiotics, the potential for universal vaccination for many major childhood illnesses, and success stories, such as the eradication of smallpox in ...References1. Broder S. Pathogenic human retroviruses (Editorial). N Engl J Med. 1988; 318:243-5. Google Scholar2. Bloom BR, Murray CJ. Tuberculosis: commentary on a reemergent killer. Science. 1992; 257:1055-64. Google Scholar3. Global Health Situation and Projections. Geneva: World Health Organization; 1992. Google Scholar4. Bennett JV, Holmberg SD, Rogers MF, Solomon SL. Infectious and parasitic diseases. In: Amler RW, Dull HB; eds. Closing the Gap: The Burden of Unnecessary Illness. New York: Oxford University Press; 1987:102-14. Google Scholar5. Leclercq R, Derlott E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988; 319:157-61. Google Scholar6. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med. 1987; 316:927-31. Google Scholar7. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992; 15:77-83. Google Scholar8. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 1992; 257:1050-5. Google Scholar9. Sloas MM, Barrett FF, Chesney PJ, English BK, Hill BC, Tenover FC, et al. Cephalosporin treatment failure in penicillin-and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 1992; 11:662-6. Google Scholar10. Tenover FC, Swenson JM, McDougal LK. Screening for extended-spectrum cephalosporin resistance in pneumococci (Letter). Lancet. 1992; 340; 1420. Google Scholar11. MacDonald KL, Osterholm MT. The emergence of Escherichia coli 0157:H7 infection in the United States. JAMA. 1993; 269:2264-6. Google Scholar12. Thacker SB, Addis DG, Goodman RA, Holloway BR, Spencer HC. Infectious diseases and injuries in child day care. Opportunities for healthier children. JAMA. 1992; 268:1720-6. Google Scholar13. Reichler MR, Allphin AA, Breiman RF. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis. 1992; 166:1346-53. Google Scholar14. Extension of the raccoon rabies epizooticUnited States, 1992. MMWR. 1992; 41:661-4. Google Scholar15. Update: choleraWestern Hemisphere, 1992. MMWR. 1993; 42:89-91. Google Scholar16. Imported cholera associated with a newly described Vibrio cholerae 0139 strainCalifornia, 1993. MMWR. 1993; 42:501-3. Google Scholar17. Marwick C. Influenza's distant early warning system. JAMA. 1993; 269:1223. Google Scholar18. Holmes GP, McCormick JB, Trock SC, Chase RA, Lewis SM, Mason CA, et al. Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med. 1990; 323: 1120-3. Google Scholar19. Schiffman MH. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst. 1992; 84:394-8. Google Scholar20. Hentschel E, Brandstatter G, Dragosics B, Hirschl AM, Nemac H, Schutz K, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med. 1993; 328:308-12. Google Scholar21. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med. 1992; 327:1899-905. Google Scholar22. Lederberg J, Shope RE, Oaks SC Jr.; eds. Emerging Infections: Microbial Threats to Health in the United States. Institute of Medicine. Washington, DC: National Academy Press; 1992. Google Scholar23. Levy SB. Confronting multidrug resistance: a role for each of us. JAMA. 1993; 269:1840-2. Google Scholar24. Kunin CM. Resistance to antimicrobial drugsA worldwide calamity. Ann Intern Med. 1993; 118:557-61. Google Scholar25. Update: hantavirus infectionUnited States. MMWR. 1993; 42: 517-9. Google Scholar Author, Article, and Disclosure InformationAffiliations: National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333.Corresponding Author: Ruth L. Berkelman, MD, National Center for Infectious Diseases, Mailstop C12, Centers for Disease Control and Prevention, Atlanta, GA 30333. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByPandemic as MethodThe Under-Appreciated Rodent: Harbingers of Plague From the Middle Ages to the Twenty-First CenturyEpidemiologic PrinciplesSpatial aberration vs. geographical substance: Representing place in public health surveillanceEpidemiologic PrinciplesBioterrorism, Fear, and Public Health Reform: Matching a Policy Solution to the Wrong WindowLight and Shadow: Perspectives on Host-Microbial Interactions in the Pathogenesis of Intensive Care Unit-Acquired InfectionThe International Health Regulations in Historical PerspectiveAntimicrobial Therapy for ICU-Acquired Infection: Time for a ReappraisalThe Global Problem of Antimicrobial ResistanceArrangement of Substrates at the Active Site of an Aminoglycoside Antibiotic 3'-Phosphotransferase As Determined by NMRActive-Site Labeling of an Aminoglycoside Antibiotic Phosphotransferase (APH(3')-IIIa)Broad Spectrum Aminoglycoside Phosphotransferase Type III from Enterococcus: Overexpression, Purification, and Substrate SpecificityInfectious Disease Surveillance: a Crumbling Foundation 1 September 1993Volume 119, Issue 5Page: 426-428KeywordsAntibioticsAntimicrobialsCholeraChronic liver diseaseDrugsGeographic areasInfectious disease controlInfectious diseasesPneumoniaPrevention, policy, and public health Issue Published: 1 September 1993 CopyrightCopyright © 1993 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...